, Volume 146, Issue 4, pp 307–320 | Cite as

Intermittent chemotherapy in pulmonary tuberculosis — Current aspects

  • Marian Zierski


A critical review of the application of various methods of intermittent chemotherapy in the initial treatment of tuberculosis and retreatment of far advanced pulmonary tuberculosis has been presented.

Not all drugs are suitable for intermittent chemotherapy in clinical practice, but the introduction in the last years of new drugs in the treatment of tuberculosis, especially rifampicin and ethambutol made possible the application of intermittent chemotherapy also for the groups of patients with far advanced chronic pulmonary tuberculosis with resistant bacilli. For intermittent chemotherapy isoniazid, rifampicin, ethambutol and streptomycin are particularly suitable in clinical practice. The intermittent chemotherapy should be applied only under strict supervision, as it requires a very good monitoring organization system. Still some problems of intermittent chemotherapy in tuberculosis are unsolved and require further studies, but the perspectives of this type of treatment seems to be very promising.


Tuberculosis Streptomycin Rifampicin Initial Treatment Critical Review 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Es wird ein kritischer Überblick über die Anwendung verschiedener Formen der intermittierenden Chemotherapie bei unvorbehandelten und bei vorbehandelten Tuberkulosen gegeben. Nicht alle antituberkulösen Mittel eignen sich für eine intermittierende Chemotherapie, doch hat die Neueinführung von Tuberkulose-Medikamenten in den letzten Jahren, insbesondere von Rifampicin und Ethambutol, die Anwendung einer intermittierenden Chemotherapie auch für Patienten mit weit fortgeschrittener, bakteriologisch resistenter Tuberkulose möglich gemacht. Für intermittierende Chemotherapie eignen sich besonders Isoniazid, Rifampicin, Ethambutol und Streptomycin. Die intermittierende Chemotherapie darf nur unter strenger Überwachung angewendet werden. Sie erfordert eine minutiöse Organisation der Kontrollen. Obwohl noch einige Probleme einer intermittierenden Chemotherapie der Tuberkulose ungelöst sind und weiterer Untersuchungen bedürfen, scheint diese Behandlungsform doch vielversprechend zu sein.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. A controlled comparison of a twice weekly and three once weekly regimes in the initial treatment of pulmonary tuberculosis. Bull. WHO43, 143 (1970).Google Scholar
  2. An international investigation of the efficacy of chemotherapy in previously untreated patients with pulmonary tuberculosis. Bull. Int. U.A.T.34, 2 (1964).Google Scholar
  3. Batten, J.: Rifampicin in the treatment of experimental tuberculosis in mice. Tubercle (Edinb.)51, 95 (1970).CrossRefPubMedGoogle Scholar
  4. Bignall, J. R.: Daily and intermittent regimes; third IUAT chemotherapy investigation. A controlled trial of three regimes of self administered and supervised chemotherapy for pulmonary tuberculosis. Clinical aspects. Bull. Un. int. Tuberc.43, 253 (1970).Google Scholar
  5. Chaulet, P., Larboui, D., Grosset, G., Abderrahim, K.: Intermittent chemotherapy with isoniazid and streptomycin in Algiers. Tubercle (Edinb.)48, 128 (1967).PubMedGoogle Scholar
  6. Daddi, G., Lucchesi, M., Mancini, P.: La rifampicyna e l'isoniazide nel tratamento intermittende della tuberculosi sperimentalle della cavia. Ann. Ist. Forlanini29, 35 (1969).PubMedGoogle Scholar
  7. Decroix, G., Kreis, B., Sors, Ch., Birenbaum, J., Le Lirzin, M., Canetti, G.: Comparaison entre les régimes rifampicine-isoniazide administré quotidiement et rifampicine-isoniazide administré deux par semaine. Rev. Tuberc. (Paris)33, 751 (1969).Google Scholar
  8. Dickinson, J. M.: The suitability of new drugs for intermittent chemotherapy of tuberculosis. Scand. J. Resp. Dis.50, Suppl. 69, 91 (1969).Google Scholar
  9. -- Mitchison, D. A.: In vitro and in vivo studies to assess the suitability of antituberculosis drugs for use in intermittent chemotherapy regimens. Tubercle (Edinb.)49, Suppl. 66 (1968).Google Scholar
  10. Farga, V.: Personal communication (1970).Google Scholar
  11. Grumbach, F., Canetti, G., Le Lirzin, M.: Rifampicin in daily and intermittent treatment of experimental murine tuberculosis with emphasis on late results. Tubercle (Edinb.)50, 3 (1969).CrossRefGoogle Scholar
  12. Poliansky, F.: Trial of sanatorium treatment including a comparison of standard and intermittent continuation chemotherapy. Bull. int. Un. Tuberc.43 (1970).Google Scholar
  13. Stradling, P., Poole, G. W.: Twice weekly streptomycin plus isoniazid for tuberculosis. Tubercle (Edinb.)51, 39 (1970).CrossRefPubMedGoogle Scholar
  14. Verbist, L.: Experimentelle Grundlagen der intermittierenden Behandlung. Pneumonologie, Suppl. 31 (1970).Google Scholar
  15. -- Gyselen, A., Landuyt, H. Van, Mbete, S., Derras, T.: Intermittent therapy with rifampicin in advanced pulmonary tuberculosis. Symposium on Rifampicin, Prague, 104 (1970).Google Scholar
  16. Zierski, M.: Intermittent rifampicin and ethambutol retreatment of resistant pulmonary tuberculosis. Symposium on rifampicin, Prague, 105 (1970).Google Scholar

Copyright information

© Springer-Verlag 1972

Authors and Affiliations

  • Marian Zierski
    • 1
  1. 1.Department of Respiratory Diseases and Tuberculosis Postgraduate Medical SchoolHospital for Lung DiseasesŁódźPoland

Personalised recommendations